11 November 2020 : Clinical Research
Serum Interleukin-6 Concentrations and the Severity of COVID-19 Pneumonia: A Retrospective Study at a Single Center in Bengbu City, Anhui Province, China, in January and February 2020
Hong Sun1CE, Pu Guo1BD, Lunjun Zhang1DF, Fengchao Wang1A*DOI: 10.12659/MSM.926941
Med Sci Monit 2020; 26:e926941
Table 2 Changes in interleukin-6 (IL-6) levels and time to progression to critical illness in patients with severe coronavirus disease-2019 (COVID-19).
| Critically ill patient (No.) | IL-6 levels at admission | IL-6 levels in critical illness | Time of progression to critical illness |
|---|---|---|---|
| 1 | 218.80 | 919.60 | 4 |
| 2 | 292.16 | 2070.00 | 5 |
| 3 | 42.59 | 745.20 | 4 |
| 4 | 40.63 | 187.00 | 3 |
| 5 | 235.00 | 2742.00 | 6 |
| 6 | 75.17 | 1557.00 | 2 |
| 7 | 28.78 | 672.10 | 7 |
| 8 | 2.55 | 1.50 | 4 |